T1	Intervention 11 74	adjuvant dose-dense chemotherapy with paclitaxel and epirubicin
T2	Intervention 159 222	adjuvant dose-dense chemotherapy with paclitaxel and epirubicin
T3	Intervention 490 619	6 cycles of chemotherapy with intravenous administration of paclitaxel (175 mg/m2, on D3) and epirubicin (60 mg/m2, on Dl and D2)
T4	Intervention 625 680	dose-dense group had repeated treatment every two weeks
T5	Intervention 692 735	regular group repeated it every three weeks
T6	Intervention 737 785	G-CSF was used in a dose of 3 microg/kg on D5-D9
T7	Intervention 1193 1219	postponing of chemotherapy
T8	Intervention 1290 1302	chemotherapy
T9	Intervention 1714 1785	Adjuvant dose-dense chemotherapy with paclitaxel and epirubicin is safe
